Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
NCT Number: NCT05179278
The objective of this study is to evaluate the impact of a program of presurgical and postsurgical nurse interventions (PROCESS-VALVE) on quality indicators of the health of patients undergoing percutaneous valve procedures. (waiting times, patient satisfaction, admission times, hospital readmission, mortality, intrahospital complications and nosocomial infections). Design of the study is an ambispective quasi-experimental study. For the control group, data will be collected retrospectively from patients undergoing percutaneous valve procedures who did not receive pre- or postsurgical consultations. The intervention group will comprise those patients who agree to participate in the study and the haemodynamic nurse valve consultation program (PROCESS-VALVE). In addition, the investigators will assess whether a face-to-face postsurgical consultation improved quality indicators compared to postsurgical telephone consultation; for this, a sub-study will be carried out comparing face-to-face or telephone postsurgical follow-up by means of a randomised controlled clinical trial with simple blinding in the intervention group. Study area will be at the Hemodynamic Unit of the Hospital de la Santa Creu i Sant Pau and the study population are chosen patients for percutaneous valvular intervention who attend the pre-surgical consultation at our center. Dependent variable will be the indicators cited in the study aim and the independent variable will be the pre-surgical and post-surgical consultation. In pre-surgical consultation will be done a patient recruitment and will collect sociodemographic and clinical data. At patient will be done an individualized interview with an Ad-Hoc questionnaire and to collect fragility level of study and level of planned connections. In the subsequent follow-up, all pacients will receive a follow-up visit and collect satisfaction and quality indicators. But this pacients will be randomized to telephone follow-up or face-to-face follow up. Sample size has been calculated in 194 to be distributed equally in both groups and the clinical trials groups will be formed by 94 patients in each group The protocol has been modified to an ambispective quasi-experimental study with a subsequent randomization for the type of follow-up (telephone vs face-to-face) due to organizational changes in the participant center.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Barcelona, 08041, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Follow-up face-to-face consultation or follow-up telephone consultation a month after the intervention and telephone consultation at one year
Time frame: Pre-intervention
Time since Heart-team accepted until the intervention
Time frame: One mounth after intervention
Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale)
Time frame: One year after intervention
Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale)
Time frame: During hospital admission ( until the last day of admission)
Time since intervention until hospital discharge
Time frame: One mounth after intervention
Hospital readminission after the intervention for cardiac reasons
Time frame: One year after intervention
Hospital readminission after the intervention for cardiac reasons
Time frame: Into admission time
Mortality for all reasons (cardiac or other reason)
Time frame: One mounth after intervention
Mortality for all reasons (cardiac or other reason)
Time frame: One year after intervention
Mortality for all reasons (cardiac or other reason)
Time frame: Into admission time
Procedure complications (vascular, stroke and cardiac complication)
Time frame: One mounth after intervention
Procedure complications (vascular, stroke and cardiac complication)
Time frame: One year after intervention
Procedure complications (vascular, stroke and cardiac complication)
Time frame: During hospital admission (until the last day of admission)
Infection adquired during hospital admission
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704086
Aortic Diseases, Arterial Occlusive Diseases
Madrid, Spain
View Trial DetailsNCT05417464
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial DetailsNCT05666713
Aortic Valve Failure, Body Temperature Changes
San Francisco, California, United States
View Trial DetailsNCT05330468
Aortic Valve Disease, Cardiovascular Diseases
Gaozhou, China
View Trial Details